Patents Assigned to AntiCancer, Inc.
  • Patent number: 7666675
    Abstract: Hair follicle stem cells are isolated from mammals by isolating nestin-expressing cells. These hair follicle stem cells are a source of adult stem cells for autologous or heterologous stem cell therapy. The stem cells can be systemically implanted into the mammal or directly implanted into the organ. In addition, the stem cells may be further differentiated in vitro and then implanted systemically or directly into the mammal.
    Type: Grant
    Filed: September 20, 2002
    Date of Patent: February 23, 2010
    Assignee: AntiCancer, Inc.
    Inventors: Lingna Li, Meng Yang
  • Publication number: 20090300779
    Abstract: Bacteria that are auxotrophic for at least two amino acids found in at least one tumor are effective anti tumor treatments, labeling agents, and vaccines against infection. Improved antitumor effects can also be provided such strains by passage through an appropriate tumor model.
    Type: Application
    Filed: June 29, 2005
    Publication date: December 3, 2009
    Applicant: ANTICANCER INC,
    Inventors: Ming Zhao, Meng Yang
  • Patent number: 7625550
    Abstract: A enhanced method for observing tumor progression, angiogenesis and/or metastasis in animal models in real time is described. The invention employs a skin flap over the area to be observed that can be opened and closed reversibly. The invention also permits simultaneous observation of more than one tumor by use of multiple colors.
    Type: Grant
    Filed: September 10, 2002
    Date of Patent: December 1, 2009
    Assignee: Anticancer, Inc.
    Inventors: Meng Yang, Eugene Baranov, Jin Wei Wang
  • Patent number: 7556825
    Abstract: The present invention describes a method for targeted and specific delivery of beneficial compounds, including hair dyes, melanin, proteins, and nucleic acids for gene therapy, to hair follicle cells using liposomes encapsulating the beneficial compound. Particularly preferred methods describe delivery of hair dyes, melanin or tyrosinase to the hair follicle for the purpose of improving hair color or condition, the delivery of compounds which prevent alopecia or stimulate hair growth, either by encapsulating a compound in liposomes, or by encapsulating a nucleic acid capable of expressing a protein in liposomes. Also described are liposome compositions for practicing the methods.
    Type: Grant
    Filed: May 7, 2004
    Date of Patent: July 7, 2009
    Assignee: Anticancer, Inc.
    Inventors: Lingna Li, Valeryi Lishko
  • Publication number: 20080058222
    Abstract: Methods of obtaining faithful expression libraries from tissue samples comprise extraction of RNA from intact tissue cultured in three-dimensional sponge-gel based histocultures.
    Type: Application
    Filed: August 7, 2007
    Publication date: March 6, 2008
    Applicant: AntiCancer, Inc.
    Inventors: Ping JIANG, Mingxu Xu, Yuying Tan
  • Patent number: 7329516
    Abstract: The present invention relates to highly conjugated proteins and methods for making such proteins. In particular, the present invention relates to methods for linking additional sites to a protein for conjugation with activated polyethylene glycol (PEG) linkers, without denaturing the protein. The invention also relates to highly conjugated proteins with decreased immunogenicity and increased circulating half-life.
    Type: Grant
    Filed: March 11, 2005
    Date of Patent: February 12, 2008
    Assignee: Anticancer, Inc.
    Inventors: Shukuan Li, Zhijian Yang, Xinghua Sun, Yuying Tan, Shigeo Yagi
  • Patent number: 7264819
    Abstract: Infection by P. carinii can be treated by administering methioninase optionally in combination with additional therapeutic agents, such as antibiotics.
    Type: Grant
    Filed: June 22, 2004
    Date of Patent: September 4, 2007
    Assignee: AntiCancer, Inc.
    Inventors: Yuying Tan, Zhijian Yang, Xinghua Sun, Shukuan Li, Qinghong Han, Mingxu Xu
  • Patent number: 7252941
    Abstract: Methods of obtaining faithful expression libraries from tissue samples comprise extraction of RNA from intact tissue cultured in three-dimensional sponge-gel based histocultures.
    Type: Grant
    Filed: November 12, 2003
    Date of Patent: August 7, 2007
    Assignee: AntiCancer, Inc.
    Inventors: Ping Jiang, Mingxu Xu, Yuying Tan
  • Patent number: 7067496
    Abstract: Methods to obtain genetic modifications of cells in histoculture are described. Modification is assisted by treating the histoculture with collagenase prior to contacting the histoculture with the delivery vehicle for the desired gene. Hair follicles and other organized tissues can be modified in this was and then transplanted into intact recipients.
    Type: Grant
    Filed: December 11, 2000
    Date of Patent: June 27, 2006
    Assignee: AntiCancer, Inc.
    Inventors: Norimitsu Saito, Ming Zhao
  • Patent number: 6927038
    Abstract: A method to determine a total cysteine in biological fluids utilizes similarly treated portions of the fluid with a homocysteinase and a non-specific desulfurase.
    Type: Grant
    Filed: November 20, 2002
    Date of Patent: August 9, 2005
    Assignee: AntiCancer, Inc.
    Inventors: Qinghong Han, Mingxu Xu, Li Tang, Yuying Tan
  • Publication number: 20050170330
    Abstract: The disclosed invention relates to the observation that nestin expression is a marker for endothelial cell proliferation. Nestin expression is particularly useful as a marker for angiogenesis, particularly for tumor-related angiogenesis. Specifically, nestin serves as an excellent endothelium marker for brain tumors such as gliomas, hemangioblastomas, Schwannomas, medulloblastomas, and meningiomas. Accordingly, the disclosed invention relates to the use of this marker as a basis to model angiogenic activity.
    Type: Application
    Filed: October 28, 2004
    Publication date: August 4, 2005
    Applicant: AntiCancer, Inc.
    Inventors: Yasuyuki Amoh, Lingna Li, Meng Yang, Ping Jiang
  • Patent number: 6916793
    Abstract: Methods for inhibiting the growth of tumor cells by combination treatment with a selenium-containing prodrug and an enzyme for which it is a substrate are described. The treatment also enhances the effect of anti-tumor agents.
    Type: Grant
    Filed: July 15, 2002
    Date of Patent: July 12, 2005
    Assignee: AntiCancer, Inc.
    Inventors: Kenji Miki, Mingxu Xu, Yuying Tan
  • Patent number: 6905831
    Abstract: Living cells can be stably modified to emit different colors from the cytoplasm and nucleus, thus permitting analysis of the status of said cells and the effect of agents on said cells either by visual or instrumentally-aided observation. These observations may be made, if desired, in real time. In addition, rates of proliferation and drug sensitivities can be determined in vitro in real time by the use of cells modified to express a single fluorescent protein and observing fluorescence intensity as a function of time.
    Type: Grant
    Filed: August 18, 2003
    Date of Patent: June 14, 2005
    Assignee: Anticancer, Inc.
    Inventors: Ping Jiang, Mingxu Xu, Meng Yang
  • Patent number: 6844326
    Abstract: A composition and method for treating and monitoring alopecia by altering hair follicle cells to produce a cell cycle inhibitor is disclosed.
    Type: Grant
    Filed: July 17, 2002
    Date of Patent: January 18, 2005
    Assignee: AntiCancer, Inc.
    Inventor: Lingna Li
  • Patent number: 6759038
    Abstract: A method to follow the progression of metastasis of a primary tumor, which method comprises removing fresh organ tissues from a vertebrate subject which has been modified to contain tumor cells that express GFP and observing the excised tissues for the presence of fluorescence is disclosed. The fluorescence can also be monitored by observing the tissues in situ. Vertebrate subjects which contain GFP producing tumors are useful models to study the mechanism of metastasis, as well as to evaluate candidate protocols and drugs. In addition, subjects already harboring tumors can be treated so as to modify the endogenous tumors to contain GFP. This permits clinical applications. Finally, by injecting a contrast dye into a subject harboring a GFP-labeled tumor, angiogenesis in the tumor can be observed directly.
    Type: Grant
    Filed: May 29, 2001
    Date of Patent: July 6, 2004
    Assignee: AntiCancer, Inc.
    Inventors: Yuying Tan, Takashi Chishima
  • Patent number: 6733776
    Abstract: The invention provides a method to provide hair growth by stimulating extrusion of hair from a hair follicle which employs a liposomal formulation of an active ingredient which stimulates extrusion when taken up by the hair follicles.
    Type: Grant
    Filed: May 20, 1997
    Date of Patent: May 11, 2004
    Assignee: AntiCancer, Inc.
    Inventors: Lingna Li, Valeryi Lishko
  • Patent number: 6713273
    Abstract: The invention provides novel methods relating to SAM detection and production as well as a novel SAHH enzymatic activity for use in such methods. Additional methods, compositions, and kits relating to the novel SAHH are also provided.
    Type: Grant
    Filed: January 12, 2001
    Date of Patent: March 30, 2004
    Assignee: AntiCancer, Inc.
    Inventors: Mingxu Xu, Qinghong Han
  • Patent number: 6653092
    Abstract: A method to detect and measure the concentration of hydrogen peroxide comprises adding reagents consisting essentially of peroxidase and a dialkyl phenylenediamine and detecting any color generated by the interaction of hydrogen peroxide with these reagents.
    Type: Grant
    Filed: October 30, 2001
    Date of Patent: November 25, 2003
    Assignee: AntiCancer, Inc.
    Inventors: Qinghong Han, Li Tang, Mingxu Xu, Yuying Tan, Shigeo Yagi
  • Patent number: 6653278
    Abstract: Methods for inhibiting the growth of tumor cells by combination treatment with a selenium-containing prodrug and an enzyme for which it is a substrate are described. The treatment also enhances the effect of anti-tumor agents.
    Type: Grant
    Filed: May 11, 2000
    Date of Patent: November 25, 2003
    Assignee: AntiCancer, Inc.
    Inventors: Kenji Miki, Mingxu Xu, Yuying Tan
  • Patent number: RE39337
    Abstract: A nude mouse model for human neoplastic diseases having histologically intact human neoplastic tissue transplanted onto an organ of the mouse which corresponds to the human organ from which the tissue is obtained.
    Type: Grant
    Filed: February 13, 1998
    Date of Patent: October 10, 2006
    Assignee: Anticancer, Inc.
    Inventors: Ann Monosov, Xinyu Fu